Health Catalyst, Inc. (NASDAQ: HCAT) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $104M. The Maz Rating grades it against the other companies in its sector.
Health Catalyst, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.37, Health Catalyst, Inc. trades at 0.4x sales and 0.7x book value. Over the last twelve months it generated about $272M of revenue and a net loss of $215M. It runs a gross margin of 44.8%, an operating margin of -20.5% and a net margin of -74.2%. It shows return on equity of -128.2%, return on invested capital of -34.2% and a free cash flow yield of 24.6%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 1.70. Over the past 52 weeks the share price ranged from $0.95 to $3.03, with a beta of 1.53.
Health Catalyst, Inc. does not currently pay a dividend.
22 Wall Street analyst ratings cover the stock: 11 Buy and 11 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.